by Tony Akiwumi | Nov 18, 2025 | Pharma / Market Access
A few years ago, two pharmaceutical companies released similar treatments within months of each other. Both had comparable science and funding. Yet one became a global success while the other vanished quietly. The difference was not in their laboratories but in their...
by Tony Akiwumi | Nov 18, 2025 | Pharma / Market Access
When the London Underground introduced the Oyster Card, resistance was fierce. Staff feared redundancy, commuters distrusted technology, and the press predicted chaos. Yet within a few years it became one of the most successful transport innovations in the world. The...
by Tony Akiwumi | Nov 18, 2025 | Pharma / Market Access
In 1961, President John F. Kennedy stood before Congress and declared that America would land a man on the moon before the decade was out. It was a vision both absurd and electrifying. It was also clear. Everyone understood what success looked like. Contrast that with...
by Tony Akiwumi | Nov 18, 2025 | Pharma / Market Access
When the British explorer Ernest Shackleton prepared for his Antarctic expedition, he spent weeks asking one question that his competitors ignored: not “How do we get there fastest?” but “How do we survive if things go wrong?” That single shift in questioning shaped...
by Tony Akiwumi | Nov 17, 2025 | Pharma / Market Access
Strategy without risk is dull. Risk without a strategy is chaos. The art lies in keeping the two in tension. Think of it like cooking a soufflé: too cautious and it never rises, too bold, and it collapses. The sweet spot lies somewhere in the middle. Most...
by Tony Akiwumi | Nov 10, 2025 | Pharma / Market Access
A few years ago, I joined a cross-functional meeting for a major launch. There were at least twenty people in the room, each representing a different function. The chart projected on the wall looked like a spider web drawn by someone who’d given up halfway through....
